Home » Medical Devices » Live Cell Imaging (LCI) Market Size, Share, Analysis Report
Live cell imaging associates with research of live cells through microscope. It helps in better understanding of characteristics and behaviour of cells. Researchers and scientists use live cell imaging for studying the biological functions.
The global Live Cell Imaging (LCI) Market is expected to exceed US$ 11 Billion by 2028, with CAGR at 9% in the given forecast period.
North America is leading market for live cell imaging industry by revenue which accounted largest share worldwide. Asia Pacific will grow with highest growth rate owing to increase in demand for live cell imaging in healthcare industry and oil and gas industryRising need of live cell imaging owing to increasing index of cancer victims is triggering the growth of the market.Its use in drug discovery is growth factor. High cost of imaging equipment is restraining factor for this market. It requires a skilled professional with immense knowledge for imaging and studying the live cells which is restraining factor.The global live cell imaging market by product equipment, consumables and software. According to its technology the market is further segmented in tofluorescence recovery after photobleaching (FRAP), fluorescence resonance energy transfer (FRET), high-content analysis (HCA), ratiometric imaging, fluorescence in situ hybridization (FISH), total internal reflection fluorescence microscopy (TRIF), multiphoton excitation microscopy (MPE) and other technologies. The application segment of live cell imaging market consists of cell biology, stem cells, developmental biology and drug discovery. The market segments in terms of geographical regions include North America, Europe, Asia-Pacific and Rest of the World(ROW).
This report provides:
1) An overview of the global market for live cell imaging and related technologies.
2) Analyses of global market trends, with data from 2021, estimates for 2022 and 2023, and projections of compound annual growth rates (CAGRs) through 2027.
3) Identifications of new market opportunities and targeted promotional plans for live cell imaging market.
4) Discussion of research and development, and the demand for new products and new applications.
5) Comprehensive company profiles of major players in the industry.
REPORT SCOPE:
The scope of the report includes a detailed study of global and regional markets for various types of coatings with the reasons given for variations in the growth of the industry in certain regions.
The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include:
• Carl Zeiss AG
• Leica Microsystems
• Nikon Corporation
• Molecular Devices LCC
• PerkinElmer Inc.
• GE Healthcare
• Becton
• Dickinson and Company
• Olympus Corporation
• Sigma Aldrich Corporation
• Thermo Fisher Scientific Inc.
Company profile includes assign such as company summary, financial summary, business strategy and planning, SWOT analysis and current developments.
The Top Companies Report is intended to provide our buyers with a snapshot of the industry’s most influential players.
The Live cell imaging Market has been segmented as below:
by Product
• Equipment
o Microscopes
? Conventional Microscopes
? Confocal Microscopes
? Advanced Fluorescence Microscopes
o Standalone Systems
o Cell Analyzers
o Image-capturing Devices
• Consumables
o Assay Kits
o Reagents
o Media
o Others
• Software
by Technology
• Fluorescence Recovery After Photobleaching (FRAP)
• Fluorescence Resonance Energy Transfer (FRET)
• High-content Analysis (HCA)
• Ratiometric Imaging
• Fluorescence In Situ Hybridization (FISH)
• Total Internal Reflection Fluorescence Microscopy (TRIF)
• Multiphoton Excitation Microscopy (MPE)
• Other Technologies
by Application
• Cell Biology
• Stem Cells
• Developmental Biology
• Drug Discovery
by Region
• North America
• Europe
• Asia Pacific
• Rest of the World (RoW)
Reasons to buy this Report:
1) Obtains the most up to date information available on all active and planned live cell imaging industry globally.
2) Identify growth segments and opportunities in the industry.
3) Facilitate decision making on the basis of strong historic and forecast of live cell imaging industry and unit capacity data.
4) Assess your competitor’s refining portfolio and its evolution.
Customization:
We can offer you custom research reports as per client’s special requirements.
Below are our new reports:
breast cancer therapeutics market
1 INTRODUCTION
1.1 Key Take Aways
1.2 Report Description
1.3 Markets Covered
1.4 Stakeholders
1.5 Research Methodology
1.5.1 Market Size
1.5.2 Market Share
1.5.3 Key Data Points From Secondary Sources
1.5.4 Key Data Points From Primary Sources
2 Research Methodology
2.1 Secondary and Primary Research Methodology
2.1.1 Secondary Research
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Research
2.1.3 Key Industry Insights
2.1.3.1 Key Data From Primary Sources
2.1.3.2 Key Insights From Primary Sources
2.2 Market Size Estimation Methodology
2.3 Market Forecast Methodology
2.4 Market Data Validation and Data Triangulation
2.5 Assumptions
3 Executive Summary
3.1 Introduction
3.2 Market Dynamics
3.2.1 Live Cell Imaging Market, By Product
3.2.2 Live Cell Imaging Instruments Market, By Type
3.2.3 Live Cell Imaging Microscopy Market, By Type
3.2.4 Live Cell Imaging Consumables Market, By Type
3.2.5 Live Cell Imaging Market, By Technology
3.2.6 Live Cell Imaging Market, By Application
3.2.7 Live Cell Imaging Market, By Region
3.3 Market Share
3.4 Competitive Landscape
3.5 Key Players
4 Premium Insights
4.1 Global Live Cell Imaging Market Size
4.2 Global Live Cell Imaging Market, By Product
4.3 Live Cell Imaging Market, By Application and Region
4.4 Live Cell Imaging Microscopes Market, By Type
4.5 Regional Snapshot
5 Market Overview
5.1 Introduction
5.2 Market Segmentation
5.3 Market Dynamics
5.3.1 Drivers
5.3.1.1 Adoption of High-Content Screening Techniques in Drug Discovery
5.3.1.2 Rising Incidence of Cancer
5.3.1.3 Government Funding for Cell-Based Research
5.3.2 Restraints
5.3.2.1 High Cost of High-Content Screening Systems
5.3.2.2 Shortage of Skilled Professionals
5.3.3 Challenge
5.3.3.1 Maintaining Cell Viability & Cellular Environment in the Culture
5.3.4 Opportunities
5.3.4.1 Asian Market Presents High-Growth Opportunities
5.3.4.2 Adoption of HCS for Primary Screening
5.3.4.3 Application of Live Cell Imaging Techniques in Personalized Medicine
6 Industry Trends
6.1 End-User Market Potential Analysis
6.1.1 Academic and Government Institutes
6.1.2 Pharmaceutical and Biotechnology Companies
6.1.3 Contract Research Organizations (CRO)
6.1.4 Diagnostic Laboratories
6.2 Supply Chain Analysis
6.2.1 Prominent Companies
6.2.2 Small and Medium Enterprises
6.2.3 End Users
6.2.4 Key Influencers
7 Market Potential Analysis
7.1 Introduction
7.2 Unmet Needs/Limiting Factors
7.3 Winning Imperatives to Boost the Adoption of Live Cell Imaging Techniques
8 Live Cell Imaging Market, By Product
8.1 Introduction
8.2 Instruments
8.2.1 Standalone Systems
8.2.2 Microscopes
8.2.2.1 Conventional Microscopes
8.2.2.2 Confocal Microscopes
8.2.2.3 Advanced Fluorescence Microscopes
8.2.3 Cell Analyzers
8.2.4 Image Capturing Devices
8.3 Consumables
8.3.1 Assay Kits
8.3.2 Reagents
8.3.3 Media
8.3.4 Other Consumables
8.4 Software
9 Live Cell Imaging Market, By Technology
9.1 Introduction
9.2 Fluorescence Resonance Energy Transfer (FRET)
9.3 Fluorescence in Situ Hybridization (FISH)
9.4 High-Content Screening (HCS)
9.5 Fluorescence Recovery After Photobleaching (FRAP)
9.6 Ratiometric Imaging
9.7 Total Internal Reflection Fluorescence Microscopy (TRIF)
9.8 Multiphoton Excitation Microscopy (MPE)
9.9 Other Technologies
10 Live Cell Imaging Market, By Application
10.1 Introduction
10.2 Cell Biology
10.3 Stem Cells
10.4 Developmental Biology
10.5 Drug Discovery
11 Live Cell Imaging Market, By Region
11.1 Introduction
11.2 North America
11.2.1 U.S.
11.2.1.1 Increasing Incidence of Cancer to Propel the Live Cell Imaging Market in the U.S.
11.2.1.2 Growth in Pharmaceutical & Biotechnology Industries in the U.S. to Drive the Market
11.2.1.3 High-Content Screening (HCS) Conferences in the U.S.
11.2.2 Canada
11.2.2.1 Increasing Investments By the Canadian Government on Regenerative Medicine to Spur Market Growth
11.2.2.2 Drug Discovery Research in Canada to Boost Market Growth
11.3 Europe
11.3.1.1 Increasing Government Funding in Europe to Drive the Market
11.3.2 U.K.
11.3.2.1 Conferences on Live Cell Imaging to Propel Market Growth
11.3.3 Germany
11.3.3.1 Advancements in Biotechnology Likely to Fuel the Live Cell Imaging Market in Germany
11.3.4 France
11.3.4.1 Advancements in the Biotechnology Sector in France
11.3.5 Rest of Europe (RoE)
11.3.5.1 Increasing Research on Regenerative Medicine in Spain to Drive the Market
11.4 Asia
11.4.1 India
11.4.1.1 Growing Pharmaceutical Industry to Spur the Market in India
11.4.2 China
11.4.2.1 Rising Burden of Cancer in China
11.4.2.2 Developing Pharmaceutical Industry in China
11.4.2.3 Increasing Government Investment in the Life Sciences Sector in China
11.4.2.4 Conferences on Live Cell Imaging in China
11.4.3 Japan
11.4.3.1 Growing Focus on Stem Cell Research in Japan
11.4.3.2 Regenerative Medicine, and Biomedical and Medical Research Set to Trigger Growth of the Live Cell Imaging Market
11.4.4 Rest of Asia (RoA)
11.4.4.1 Increasing Government Support for Strong Academic and Commercial R&D Activities in Taiwan
11.4.5 Rest of the World (RoW)
11.4.5.1 Flourishing Biotechnology and Pharmaceutical Markets in Brazil
11.4.5.2 Significant Developments in the Pharmaceutical Market in Africa
12 Competitive Landscape
12.1 Market Share Analysis
12.1.1 Introduction
12.1.2 Carl Zeiss AG
12.1.3 Nikon Corporation
12.1.4 Leica Microsystems (Acquired By Danaher Corporation)
12.2 Competitive Situation and Trends
12.2.1 Introduction
12.2.2 New Product Launches
12.2.3 Agreements/Partnerships/Collaborations
12.2.4 Expansions
12.2.5 Acquisitions
12.2.6 Others
The Live cell imaging Market has been segmented as below:
by Product
• Equipment
o Microscopes
? Conventional Microscopes
? Confocal Microscopes
? Advanced Fluorescence Microscopes
o Standalone Systems
o Cell Analyzers
o Image-capturing Devices
• Consumables
o Assay Kits
o Reagents
o Media
o Others
• Software
by Technology
• Fluorescence Recovery After Photobleaching (FRAP)
• Fluorescence Resonance Energy Transfer (FRET)
• High-content Analysis (HCA)
• Ratiometric Imaging
• Fluorescence In Situ Hybridization (FISH)
• Total Internal Reflection Fluorescence Microscopy (TRIF)
• Multiphoton Excitation Microscopy (MPE)
• Other Technologies
by Application
• Cell Biology
• Stem Cells
• Developmental Biology
• Drug Discovery
by Region
• North America
• Europe
• Asia Pacific
• Rest of the World (RoW)